Tbo-filgrastim Interactions
There are 175 drugs known to interact with tbo-filgrastim, along with 3 disease interactions. Of the total drug interactions, 3 are major, and 172 are moderate.
- View tbo-filgrastim disease interactions (3)
Medications known to interact with tbo-filgrastim
Note: Showing generic names only.
- abemaciclib
- acalabrutinib
- aldesleukin
- alemtuzumab
- altretamine
- arsenic trioxide
- asciminib
- asparaginase escherichia coli
- avapritinib
- axicabtagene ciloleucel
- azacitidine
- belantamab mafodotin
- belinostat
- bendamustine
- betibeglogene autotemcel
- bevacizumab
- bexarotene
- bleomycin
- blinatumomab
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- busulfan
- cabazitaxel
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- chlorambucil
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- copanlisib
- crizotinib
- cyclophosphamide
- cytarabine
- dacarbazine
- dactinomycin
- daratumumab
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- dinutuximab
- docetaxel
- doxorubicin
- doxorubicin liposomal
- duvelisib
- eflornithine
- elranatamab
- enfortumab vedotin
- epcoritamab
- epirubicin
- eribulin
- etoposide
- exagamglogene autotemcel
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- imetelstat
- inavolisib
- inotuzumab ozogamicin
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon gamma-1b
- iobenguane I 131
- iodine i 131 tositumomab
- irinotecan
- irinotecan liposomal
- isatuximab
- ixabepilone
- ixazomib
- lenalidomide
- levamisole
- lifileucel
- lisocabtagene maraleucel
- lithium
- lomustine
- loncastuximab tesirine
- lovotibeglogene autotemcel
- lurbinectedin
- mechlorethamine
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- midostaurin
- mitomycin
- mitoxantrone
- mosunetuzumab
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- panobinostat
- pazopanib
- pegaspargase
- peginterferon alfa-2a
- peginterferon alfa-2b
- pemetrexed
- pentostatin
- pirtobrutinib
- plicamycin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- pralatrexate
- procarbazine
- tafasitamab
- talazoparib
- talquetamab
- teclistamab
- temozolomide
- teniposide
- thalidomide
- thioguanine
- thiotepa
- tisagenlecleucel
- tisotumab vedotin
- topotecan
- tositumomab
- trabectedin
- trastuzumab
- treosulfan
- trimetrexate
Tbo-filgrastim disease interactions
There are 3 disease interactions with tbo-filgrastim which include:
Report options
More about tbo-filgrastim
- tbo-filgrastim consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: colony stimulating factors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Zarxio
Zarxio (filgrastim-sndz) is biosimilar product used to treat neutropenia associated with ...
Neulasta
Neulasta is used to stimulate neutrophil growth and reduce infection risk (manifested by febrile ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Neupogen
Neupogen (filgrastim) is used to treat neutropenia, a lack of certain white blood cells caused by ...
Nivestym
Nivestym is used for bone marrow transplantation, neutropenia, neutropenia associated with ...
Fulphila
Fulphila is used for febrile neutropenia, neutropenia associated with chemotherapy
Udenyca
Udenyca is used for febrile neutropenia, hematopoietic syndrome of acute radiation syndrome ...
Releuko
Releuko is used for bone marrow transplantation, neutropenia, neutropenia associated with chemotherapy
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.